Janus kinase 2/JAK2 Protein, Human (sf9)

The Janus kinase 2 (JAK2) protein is a critical non-receptor tyrosine kinase that drives important cellular processes affecting growth, development, differentiation, and histone modifications. JAK2 plays a role in innate and adaptive immunity, interacting with receptors such as growth hormone, erythropoietin, and interleukins. Janus kinase 2/JAK2 Protein, Human (sf9) is the recombinant human-derived Janus kinase 2/JAK2, expressed by Sf9 insect cells , with tag Free labeled tag. ,

Janus kinase 2 (JAK2) protein, a non-receptor tyrosine kinase, orchestrates critical cellular processes such as cell growth, development, differentiation, and histone modifications. Operating in both innate and adaptive immunity, JAK2 engages with various receptors, including growth hormone, prolactin, leptin, erythropoietin, thrombopoietin, interferons, and interleukins. Upon ligand binding, JAK2 phosphorylates receptor tyrosine residues, creating docking sites for STAT proteins. This initiates a signaling cascade leading to STAT activation, homodimer or heterodimer formation, and nuclear translocation, ultimately promoting gene transcription. In erythropoiesis, for instance, JAK2 activation by erythropoietin induces STAT5-mediated transcription of crucial genes. JAK2 also participates in signaling cascades activated by cellular retinol and mediates angiotensin-2-induced ARHGEF1 phosphorylation. Furthermore, JAK2 plays a role in the cell cycle by phosphorylating CDKN1B and cooperates with TEC to activate FOS transcription. Intriguingly, in the nucleus, JAK2's involvement extends to chromatin regulation through the phosphorylation of histone H3 at Tyr-41, influencing chromatin structure and function.

Human

Sf9 insect cells

Tag Free

O60674-1 (T842-G1132)

3717

Greater than 80 % as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.